Comparative RNAi Screens in Isogenic Human Stem Cells Reveal SMARCA4 as a Differential Regulator.


Journal

Stem cell reports
ISSN: 2213-6711
Titre abrégé: Stem Cell Reports
Pays: United States
ID NLM: 101611300

Informations de publication

Date de publication:
14 05 2019
Historique:
received: 04 12 2018
revised: 26 03 2019
accepted: 27 03 2019
pubmed: 30 4 2019
medline: 28 4 2020
entrez: 30 4 2019
Statut: ppublish

Résumé

Large-scale RNAi screens are a powerful approach to identify functions of genes in a cell-type-specific manner. For model organisms, genetically identical (isogenic) cells from different cell types are readily available, making comparative studies meaningful. However, large-scale screens in isogenic human primary cells remain challenging. Here, we show that RNAi screens are possible in genetically identical human stem cells, using induced pluripotent stem cells as intermediates. The screens revealed SMARCA4 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4) as a stemness regulator, while balancing differentiation distinctively for each cell type. SMARCA4 knockdown in hematopoietic stem and progenitor cells caused impaired self-renewal in vitro and in vivo with skewed myeloid differentiation; whereas, in neural stem cells, it impaired self-renewal while biasing differentiation toward neural lineage, through combinatorial SWI/SNF subunit assembly. Our findings pose a powerful approach for deciphering human stem cell biology and attribute distinct roles to SMARCA4 in stem cell maintenance.

Identifiants

pubmed: 31031192
pii: S2213-6711(19)30097-9
doi: 10.1016/j.stemcr.2019.03.012
pmc: PMC6523874
pii:
doi:

Substances chimiques

Nuclear Proteins 0
Transcription Factors 0
SMARCA4 protein, human EC 3.6.1.-
DNA Helicases EC 3.6.4.-

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1084-1098

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Nat Rev Mol Cell Biol. 2006 Mar;7(3):177-87
pubmed: 16496020
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
Nature. 2002 Jul 11;418(6894):195-9
pubmed: 12110891
Stem Cell Rev Rep. 2012 Mar;8(1):32-42
pubmed: 21526416
J Cell Physiol. 2006 Jan;206(1):112-8
pubmed: 15965950
PLoS One. 2013;8(3):e59252
pubmed: 23533608
Blood. 2015 Jun 11;125(24):3760-8
pubmed: 25931586
PLoS One. 2013 Sep 17;8(9):e72884
pubmed: 24069164
Nature. 2008 May 15;453(7193):306-13
pubmed: 18480811
Nat Cell Biol. 2018 Jun;20(6):710-720
pubmed: 29802403
Genome Biol. 2016 Aug 17;17(1):173
pubmed: 27534536
Nat Methods. 2014 Apr;11(4):436-42
pubmed: 24562423
J Cell Mol Med. 2016 Aug;20(8):1571-88
pubmed: 27097531
Stem Cell Reports. 2014 Sep 9;3(3):460-74
pubmed: 25241744
Hematology Am Soc Hematol Educ Program. 2003;:398-418
pubmed: 14633792
Epigenomics. 2017 Jun;9(6):919-931
pubmed: 28521512
Blood. 2017 Jun 22;129(25):3344-3351
pubmed: 28408459
Genome Res. 2016 Sep;26(9):1188-201
pubmed: 27435934
J Med Chem. 2016 May 26;59(10):4800-11
pubmed: 27115555
Science. 2011 Jul 8;333(6039):218-21
pubmed: 21737740
Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1470-4
pubmed: 8643656
Mol Cancer. 2010 Oct 22;9:280
pubmed: 20969766
Genome Res. 2014 Jun;24(6):920-9
pubmed: 24752179
Oncotarget. 2018 May 22;9(39):25458-25473
pubmed: 29876001
Science. 2014 Sep 19;345(6203):1509-12
pubmed: 25237102
J Zhejiang Univ Sci B. 2013 Dec;14(12):1059-69
pubmed: 24302707
Cell. 1997 Nov 28;91(5):661-72
pubmed: 9393859
Blood Adv. 2018 Jul 10;2(13):1628-1632
pubmed: 29986855
Blood. 2012 Jun 28;119(26):6255-8
pubmed: 22555972
Nature. 2000 Mar 9;404(6774):193-7
pubmed: 10724173
FEBS Lett. 2014 Aug 1;588(15):2415-21
pubmed: 24950427
Cell. 2008 Feb 22;132(4):631-44
pubmed: 18295580
Trends Biochem Sci. 1995 Apr;20(4):143-6
pubmed: 7770913
Cell Rep. 2016 Mar 29;14(12):2988-3000
pubmed: 26997282
Dev Biol. 2006 Jan 15;289(2):372-83
pubmed: 16330018
Cancer Res. 2015 Sep 15;75(18):3865-3878
pubmed: 26139243
Blood. 2009 Apr 16;113(16):3690-5
pubmed: 19188664
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12311-5
pubmed: 10535918
Neuron. 2007 Jul 19;55(2):201-15
pubmed: 17640523
J Biol Chem. 2006 Dec 22;281(51):38974-80
pubmed: 17023429
Genes Dev. 2005 May 15;19(10):1129-55
pubmed: 15905405
Nat Immunol. 2015 Jul;16(7):775-84
pubmed: 25985234
Blood Cancer J. 2011 Sep;1(9):e36
pubmed: 22829197
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Cell Tissue Res. 2014 Jun;356(3):575-84
pubmed: 24496512
Nature. 2017 May 25;545(7655):432-438
pubmed: 28514439
J Exp Med. 2003 Feb 17;197(4):413-23
pubmed: 12591900
Cell Stem Cell. 2014 Aug 7;15(2):227-38
pubmed: 25017720
Cell Syst. 2015 Aug 26;1(2):141-51
pubmed: 27135800
Science. 2007 Dec 21;318(5858):1917-20
pubmed: 18029452
Nucl Recept Signal. 2008 Feb 01;6:e004
pubmed: 18301784
J Immunol. 2012 Apr 15;188(8):3791-803
pubmed: 22427636
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5181-6
pubmed: 19279220

Auteurs

Ceren Güneş (C)

Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, 01307 Dresden, Germany.

Maciej Paszkowski-Rogacz (M)

Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, 01307 Dresden, Germany.

Susann Rahmig (S)

Regeneration in Hematopoiesis, Leibniz Institute on Aging - Fritz Lipmann Institute, 07745 Jena, Germany.

Shahryar Khattak (S)

Stem Cell Engineering Facility, Biotechnology Center, TU Dresden, 01307 Dresden, Germany.

Aylin Camgöz (A)

Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, 01307 Dresden, Germany; National Center for Tumor Diseases (NCT), University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.

Martin Wermke (M)

Department of Medicine I, University Hospital Carl Gustav Carus, 01307 Dresden, Germany; Medical Faculty and University Hospital Carl Gustav Carus, Early Clinical Trial Unit, 01307 Dresden, Germany.

Andreas Dahl (A)

Dresden Genome Center (DGC), TU Dresden, 01307 Dresden, Germany.

Martin Bornhäuser (M)

Department of Medicine I, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.

Claudia Waskow (C)

Regeneration in Hematopoiesis, Leibniz Institute on Aging - Fritz Lipmann Institute, 07745 Jena, Germany; Department of Medicine III, Faculty of Medicine, Fetscherstrasse 74, 01307 Dresden, Germany.

Frank Buchholz (F)

Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, 01307 Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg and German Research Consortium (DKTK), Partner Site Dresden, 01307 Dresden, Germany; National Center for Tumor Diseases (NCT), University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany. Electronic address: frank.buchholz@tu-dresden.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH